Page last updated: 2024-10-29

iohexol and Lymphangioleiomyomatosis

iohexol has been researched along with Lymphangioleiomyomatosis in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Lymphangioleiomyomatosis: A disease characterized by the progressive invasion of SMOOTH MUSCLE CELLS into the LYMPHATIC VESSELS, and the BLOOD VESSELS. The majority of the cases occur in the LUNGS of women of child-bearing age, eventually blocking the flow of air, blood, and lymph. The common symptom is shortness of breath (DYSPNEA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attili, AK1
Kazerooni, EA1

Other Studies

1 other study available for iohexol and Lymphangioleiomyomatosis

ArticleYear
Case 116: lymphangioleiomyomatosis.
    Radiology, 2007, Volume: 244, Issue:1

    Topics: Contrast Media; Diagnosis, Differential; Diatrizoate; Female; Humans; Iohexol; Lung Neoplasms; Lymph

2007